Lunac Therapeutics
PrivateLast Round
VC Round
May 13, 2021
Total Funding Raised
$7.45M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Lunac Therapeutics operates in Healthcare & Life Sciences and is based in Leeds. Its latest recorded funding round was a VC Round in May 2021.
Lunac Therapeutics is a drug discovery company developing next-generation oral anticoagulants to treat and prevent thrombotic events without the bleeding risk associated with current therapies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lunac Therapeutics Comparables
Compare Lunac Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aronora, Inc. | 84% | |
| Novartis | 77% | |
| Bayer AG | 74% |
For institutional investors. Book with your work email.
Lunac Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 13, 2021 | ||||
| Grant | Dec 12, 2019 | ||||
| Series A | Nov 14, 2019 |
For institutional investors. Book with your work email.
Lunac Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Leeds | Series A |
| Epidarex Capital | VC Round, Series A |
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 36% MoM.
- Jun 18, 2026
Monthly visitors increased 81% MoM.
For institutional investors. Book with your work email.
Lunac Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lunac Therapeutics's valuation, stock price, and market status.
Is Lunac Therapeutics a public or private company?
Lunac Therapeutics is a private company.
What is the current stock price of Lunac Therapeutics?
Lunac Therapeutics is a private company, so its shares have no public market price. Caplight tracks Lunac Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lunac Therapeutics worth (valuation)?
Valuation information for Lunac Therapeutics is not publicly available.
Can I buy Lunac Therapeutics stock?
Lunac Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lunac Therapeutics's last funding round?
Lunac Therapeutics's most recent funding round was VC Round on May 13, 2021.
Who are the main investors in Lunac Therapeutics?
Key investors in Lunac Therapeutics include University of Leeds, Epidarex Capital, Innovate UK.
Will Lunac Therapeutics IPO soon?
No public IPO plans have been announced for Lunac Therapeutics.
How can I track Lunac Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Lunac Therapeutics's shares on secondary markets.